Zymeworks BC Inc
ZYME
Market Cap$882.89M
Close$
$-13.17
203.9% downside
Current Fair Value
203.9% downsideOvervalued by 203.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $882.89 Million |
|---|---|
| Enterprise Value | $848.77 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.62 |
| Beta | 1.18 |
| Outstanding Shares | 75,171,020 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.38 |
|---|---|
| PEG | 29.41 |
| Price to Sales | - |
| Price to Book Ratio | 3.17 |
| Enterprise Value to Revenue | 11.45 |
| Enterprise Value to EBIT | -0.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Zymeworks Inc
CEO: Ali Tehrani